Liquidia Corp’s recent filing unveils that its Chief Medical Officer Saggar Rajeev unloaded Company’s shares for reported $22558.0 on Apr 19 ’24. In the deal valued at $13.68 per share,1,649 shares were sold. As a result of this transaction, Saggar Rajeev now holds 211,672 shares worth roughly $2.69 million.
Then, JEFFS ROGER sold 8,360 shares, generating $121,889 in total proceeds. Upon selling the shares at $14.58, the Chief Executive Officer now owns 826,985 shares.
Before that, Kaseta Michael sold 3,136 shares. Liquidia Corp shares valued at $45,723 were divested by the CFO and COO at a price of $14.58 per share. As a result of the transaction, Kaseta Michael now holds 315,045 shares, worth roughly $4.0 million.
Needham reiterated its Liquidia Corp [LQDA] rating to a Buy in a research note published on January 05, 2024; the price target was $28. Wedbush also remained covering LQDA and has decreased its forecast on September 01, 2022 with a “an Underperform” recommendation from previously “Neutral” rating. Ladenburg Thalmann started covering the stock on July 22, 2022. It rated LQDA as “a Buy”.
Price Performance Review of LQDA
On Monday, Liquidia Corp [NASDAQ:LQDA] saw its stock fall -0.78% to $12.69. Over the last five days, the stock has gained 1.81%. Liquidia Corp shares have risen nearly 5.49% since the year began. Nevertheless, the stocks have risen 73.36% over the past one year. While a 52-week high of $16.99 was reached on 03/22/24, a 52-week low of $5.71 was recorded on 01/25/24. SMA at 50 days reached $14.32, while 200 days put it at $10.07. A total of 0.7 million shares were traded, compared to the trading of 0.48 million shares in the previous session.
Levels Of Support And Resistance For LQDA Stock
The 24-hour chart illustrates a support level at 12.55, which if violated will result in even more drops to 12.40. On the upside, there is a resistance level at 12.96. A further resistance level may holdings at 13.23. The Relative Strength Index (RSI) on the 14-day chart is 38.11, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.14, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 63.52%. Stochastics %K at 40.64% indicates the stock is a holding.
The most recent change occurred on May 31, 2022 when BTIG Research began covering the stock and recommended ‘”a Buy”‘ rating along with a $14 price target.
